APDN

BNB Plus Corp. (APDN) | Rumor.io

BNB Plus

APDN

Attention (50-day avg)0%

Attention rank (50-day avg)#4,725

Bullish sentiment (50-day avg)0%

Price to earnings ratio0

Market capitalization486.9K

Earnings per share-57.1

Dividend yield (TTM)—

Revenue (annual)3.4M

Net income (annual)-7.1M

Social

What share of all stock conversation is about APDN?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% new	0% -0.01

Nov 13

Applied DNA Sciences, Inc. ($APDN) is being watched for its sequencing technology.
There is hype around DNA storage, but some are cautioning about a potential downside.
Investors are optimistic about $APDN's potential, with some seeing it as a strong performer.

Generated by AI

Sentiment

Of the messages about APDN that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	86.26% +9.56
Bearish	—	—	—	13.74% -9.56

Bullish· Sep 29

$APDN has shown significant accumulation in the last 2 sessions, potentially leading to further price increases.
The company has experienced multiple trading halts due to high volatility, indicating strong investor interest and a low float, which could lead to further price gains.
$APDN has been compared to $GME, a stock that has experienced significant price increases, suggesting that $APDN could be the next big mover in the market.

Bearish· Apr 7

$APDN has declined by 50% since its price was last mentioned, indicating a significant loss of value.
The company's insiders have dumped their shares, which may indicate a lack of confidence in the company's future prospects.
$APDN's technical analysis suggests that it is approaching a target bottom zone, potentially indicating a continued downward trend.

Generated by AI

Topics

Of the messages about APDN that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	8.38%
Announcements	—	—	—	48.47%
Controversies	—	—	—	0.2%
Earnings	—	—	—	0%
Macro	—	—	—	22.49%
Technical Analysis	—	—	—	20.45%

Earnings· May 3

Applied DNA Sciences beat earnings estimates by $0.05 and revenue estimates.
The company will host a Q2 earnings call at 4:30 PM Eastern, which can be streamed live or replayed later.
Applied DNA Sciences has reported its fiscal second quarter 2018 financial results.

Announcements· Nov 13

Applied DNA Sciences, Inc. (APDN) announces its sequencing watch, highlighting its potential applications.
The company's sequencing watch is expected to have a significant impact, with some users expressing excitement and anticipation.
APDN's sequencing watch is seen as a major development, with some users comparing it to a "game-changer" in the field.

Technical Analysis· Oct 13

$APDN has a strong daily reversal at 2.38, which was a key level, and bulls want to maintain the hourly uptrend above 2.39.
The hourly chart shows that bulls need to maintain above 2.51 support, and bears will look to top fish the high of premarket.
$APDN has broken an ascending triangle pattern, and a break above 3 would trigger a bigger move towards 4-5.

Generated by AI

Community

Of the messages about APDN, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	0%	69.89%
Newcomers	100%	100%	100%	30.11%

Regulars· Sep 29

Applied DNA Sciences appointed Anthony Scaramucci as an adviser, potentially bringing more attention and investment to the company.
The company's stock price has been highly volatile, with some users expressing excitement about the potential for further price increases.
A private placement of up to $58 million was announced, which some users see as a positive development that could lead to future growth and investment in the company.

Newcomers· Nov 13

Newcomers to $APDN are focused on its potential for DNA sequencing and storage, with some expressing excitement and hype around the technology.
Some newcomers are concerned about the cooling of DNA storage hype and the potential downside brewing, which could impact $APDN's value.
Others are focused on $APDN's growth and potential for a successful launch, with some using enthusiastic and celebratory language to express their optimism.

Generated by AI

News

China targets US firms and drone exports after FCC, Xinjiang actions

1mo agoReuters

'No choice but to take necessary countermeasures': China imposes sanctions on Washington in retaliation to U.S. trade restrictions | Fortune

China just levied controls on drone exports as Chinese President Xi Jinping prepares to meet with US President Donald trump in September.

1mo agoFortune

Also Discussed

Investors talking about APDN also mention

#	Name	Attention
1	BIMI - BIMI International Medical Inc.	——
2	GeoVax Labs, Inc.GOVX	0%+0
3	BWV - Blue Water Vaccines, Inc.	——
4	Virax Biolabs Group Ltd.VRAX	0%+0
5	Intelligent Living Application Group Inc.ILAG	0%new
6	Textron Inc.TXT	0.01%new
7	TGI - Triumph Group, Inc.	——
8	VSE Corporation Common StockVSEC	0%new
9	OPOF - Old Point Financial Corporation	——
10	Rail Vision Ltd.RVSN	0%0

BNB Plus Corp.

Financial Services
Asset Management

BNB Plus Corp. is a diversified biotechnology and digital asset treasury company originally founded in 1983. It operates through three main segments: Therapeutic DNA Production Services, which focuses on enzymatic manufacturing of synthetic DNA for nucleic acid-based therapeutics; MDx Testing Services, offering clinical molecular diagnostic and genetic testing solutions; and DNA Tagging and Security Products and Services, which provide authentication and provenance verification through proprietary molecular tagging technologies. The company has recently rebranded from Applied DNA Sciences to BNB Plus Corp., reflecting a new strategic initiative centered on building an actively managed digital asset treasury with a focus on BNB (Binance Coin) exposure and yield generation through the Binance ecosystem. With institutional-grade digital asset management linked to blockchain and DeFi innovations, BNB Plus Corp. aims to blend biopharmaceutical technologies with emerging crypto-asset strategies, positioning itself at the intersection of life sciences and digital finance.

Website

Location

50 Health Sciences Drive

Stony Brook, NY, 11790

United States

Social

What share of all stock conversation is about APDN?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% new	0% -0.01

Nov 13

Applied DNA Sciences, Inc. ($APDN) is being watched for its sequencing technology.
There is hype around DNA storage, but some are cautioning about a potential downside.
Investors are optimistic about $APDN's potential, with some seeing it as a strong performer.

Generated by AI

Sentiment

Of the messages about APDN that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	86.26% +9.56
Bearish	—	—	—	13.74% -9.56

Bullish· Sep 29

$APDN has shown significant accumulation in the last 2 sessions, potentially leading to further price increases.
The company has experienced multiple trading halts due to high volatility, indicating strong investor interest and a low float, which could lead to further price gains.
$APDN has been compared to $GME, a stock that has experienced significant price increases, suggesting that $APDN could be the next big mover in the market.

Bearish· Apr 7

$APDN has declined by 50% since its price was last mentioned, indicating a significant loss of value.
The company's insiders have dumped their shares, which may indicate a lack of confidence in the company's future prospects.
$APDN's technical analysis suggests that it is approaching a target bottom zone, potentially indicating a continued downward trend.

Generated by AI

Topics

Of the messages about APDN that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	8.38%
Announcements	—	—	—	48.47%
Controversies	—	—	—	0.2%
Earnings	—	—	—	0%
Macro	—	—	—	22.49%
Technical Analysis	—	—	—	20.45%

Earnings· May 3

Applied DNA Sciences beat earnings estimates by $0.05 and revenue estimates.
The company will host a Q2 earnings call at 4:30 PM Eastern, which can be streamed live or replayed later.
Applied DNA Sciences has reported its fiscal second quarter 2018 financial results.

Announcements· Nov 13

Applied DNA Sciences, Inc. (APDN) announces its sequencing watch, highlighting its potential applications.
The company's sequencing watch is expected to have a significant impact, with some users expressing excitement and anticipation.
APDN's sequencing watch is seen as a major development, with some users comparing it to a "game-changer" in the field.

Technical Analysis· Oct 13

$APDN has a strong daily reversal at 2.38, which was a key level, and bulls want to maintain the hourly uptrend above 2.39.
The hourly chart shows that bulls need to maintain above 2.51 support, and bears will look to top fish the high of premarket.
$APDN has broken an ascending triangle pattern, and a break above 3 would trigger a bigger move towards 4-5.

Generated by AI

Community

Of the messages about APDN, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	0%	69.89%
Newcomers	100%	100%	100%	30.11%

Regulars· Sep 29

Applied DNA Sciences appointed Anthony Scaramucci as an adviser, potentially bringing more attention and investment to the company.
The company's stock price has been highly volatile, with some users expressing excitement about the potential for further price increases.
A private placement of up to $58 million was announced, which some users see as a positive development that could lead to future growth and investment in the company.

Newcomers· Nov 13

Newcomers to $APDN are focused on its potential for DNA sequencing and storage, with some expressing excitement and hype around the technology.
Some newcomers are concerned about the cooling of DNA storage hype and the potential downside brewing, which could impact $APDN's value.
Others are focused on $APDN's growth and potential for a successful launch, with some using enthusiastic and celebratory language to express their optimism.

Generated by AI

BNB Plus

Social

Nov 13

Bullish· Sep 29

Bearish· Apr 7

Earnings· May 3

Announcements· Nov 13

Technical Analysis· Oct 13

Regulars· Sep 29

Newcomers· Nov 13

China targets US firms and drone exports after FCC, Xinjiang actions

'No choice but to take necessary countermeasures': China imposes sanctions on Washington in retaliation to U.S. trade restrictions | Fortune

Also Discussed

BNB Plus Corp.

Company Information

Location

China targets US firms and drone exports after FCC, Xinjiang actions

'No choice but to take necessary countermeasures': China imposes sanctions on Washington in retaliation to U.S. trade restrictions | Fortune

Also Discussed

Social

Nov 13

Bullish· Sep 29

Bearish· Apr 7

Earnings· May 3

Announcements· Nov 13

Technical Analysis· Oct 13

Regulars· Sep 29

Newcomers· Nov 13